These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
304 related articles for article (PubMed ID: 19889714)
1. Reduction of basal forebrain cholinergic system parallels cognitive impairment in patients at high risk of developing Alzheimer's disease. Grothe M; Zaborszky L; Atienza M; Gil-Neciga E; Rodriguez-Romero R; Teipel SJ; Amunts K; Suarez-Gonzalez A; Cantero JL Cereb Cortex; 2010 Jul; 20(7):1685-95. PubMed ID: 19889714 [TBL] [Abstract][Full Text] [Related]
2. The cholinergic system in mild cognitive impairment and Alzheimer's disease: an in vivo MRI and DTI study. Teipel SJ; Meindl T; Grinberg L; Grothe M; Cantero JL; Reiser MF; Möller HJ; Heinsen H; Hampel H Hum Brain Mapp; 2011 Sep; 32(9):1349-62. PubMed ID: 20672311 [TBL] [Abstract][Full Text] [Related]
3. Atrophy of the cholinergic Basal forebrain over the adult age range and in early stages of Alzheimer's disease. Grothe M; Heinsen H; Teipel SJ Biol Psychiatry; 2012 May; 71(9):805-13. PubMed ID: 21816388 [TBL] [Abstract][Full Text] [Related]
4. In vivo cholinergic basal forebrain atrophy predicts cognitive decline in de novo Parkinson's disease. Ray NJ; Bradburn S; Murgatroyd C; Toseeb U; Mir P; Kountouriotis GK; Teipel SJ; Grothe MJ Brain; 2018 Jan; 141(1):165-176. PubMed ID: 29228203 [TBL] [Abstract][Full Text] [Related]
5. Atrophy of the cholinergic basal forebrain in dementia with Lewy bodies and Alzheimer's disease dementia. Grothe MJ; Schuster C; Bauer F; Heinsen H; Prudlo J; Teipel SJ J Neurol; 2014 Oct; 261(10):1939-48. PubMed ID: 25059393 [TBL] [Abstract][Full Text] [Related]
6. Volume Loss of the Nucleus Basalis of Meynert is Associated with Atrophy of Innervated Regions in Mild Cognitive Impairment. Cantero JL; Zaborszky L; Atienza M Cereb Cortex; 2017 Aug; 27(8):3881-3889. PubMed ID: 27371762 [TBL] [Abstract][Full Text] [Related]
7. Measurement of basal forebrain atrophy in Alzheimer's disease using MRI. Teipel SJ; Flatz WH; Heinsen H; Bokde AL; Schoenberg SO; Stöckel S; Dietrich O; Reiser MF; Möller HJ; Hampel H Brain; 2005 Nov; 128(Pt 11):2626-44. PubMed ID: 16014654 [TBL] [Abstract][Full Text] [Related]
8. Structural degeneration of the nucleus basalis of Meynert in mild cognitive impairment and Alzheimer's disease - Evidence from an MRI-based meta-analysis. Mieling M; Meier H; Bunzeck N Neurosci Biobehav Rev; 2023 Nov; 154():105393. PubMed ID: 37717861 [TBL] [Abstract][Full Text] [Related]
10. Basal forebrain volume reliably predicts the cortical spread of Alzheimer's degeneration. Fernández-Cabello S; Kronbichler M; Van Dijk KRA; Goodman JA; Spreng RN; Schmitz TW; Brain; 2020 Mar; 143(3):993-1009. PubMed ID: 32203580 [TBL] [Abstract][Full Text] [Related]
11. Independent and additive contribution of white matter hyperintensities and Alzheimer's disease pathology to basal forebrain cholinergic system degeneration. Kindler C; Upadhyay N; Bendella Z; Dorn F; Keil VC; Petzold GC Neuroimage Clin; 2023; 39():103477. PubMed ID: 37478584 [TBL] [Abstract][Full Text] [Related]
12. The cholinergic system in aging and neuronal degeneration. Schliebs R; Arendt T Behav Brain Res; 2011 Aug; 221(2):555-63. PubMed ID: 21145918 [TBL] [Abstract][Full Text] [Related]
13. Reduced basal forebrain atrophy progression in a randomized Donepezil trial in prodromal Alzheimer's disease. Cavedo E; Grothe MJ; Colliot O; Lista S; Chupin M; Dormont D; Houot M; Lehéricy S; Teipel S; Dubois B; Hampel H; Sci Rep; 2017 Sep; 7(1):11706. PubMed ID: 28916821 [TBL] [Abstract][Full Text] [Related]
14. Association of basal forebrain volumes and cognition in normal aging. Wolf D; Grothe M; Fischer FU; Heinsen H; Kilimann I; Teipel S; Fellgiebel A Neuropsychologia; 2014 Jan; 53():54-63. PubMed ID: 24269297 [TBL] [Abstract][Full Text] [Related]
16. Atrophy of Basal Forebrain Initiates with Tau Pathology in Individuals at Risk for Alzheimer's Disease. Cantero JL; Atienza M; Lage C; Zaborszky L; Vilaplana E; Lopez-Garcia S; Pozueta A; Rodriguez-Rodriguez E; Blesa R; Alcolea D; Lleo A; Sanchez-Juan P; Fortea J; Cereb Cortex; 2020 Apr; 30(4):2083-2098. PubMed ID: 31799623 [TBL] [Abstract][Full Text] [Related]
17. Diffusion tensor imaging in Alzheimer's disease and mild cognitive impairment. Stebbins GT; Murphy CM Behav Neurol; 2009; 21(1):39-49. PubMed ID: 19847044 [TBL] [Abstract][Full Text] [Related]
18. Subregional basal forebrain atrophy in Alzheimer's disease: a multicenter study. Kilimann I; Grothe M; Heinsen H; Alho EJ; Grinberg L; Amaro E; Dos Santos GA; da Silva RE; Mitchell AJ; Frisoni GB; Bokde AL; Fellgiebel A; Filippi M; Hampel H; Klöppel S; Teipel SJ J Alzheimers Dis; 2014; 40(3):687-700. PubMed ID: 24503619 [TBL] [Abstract][Full Text] [Related]
19. Posterior cingulate cortex atrophy and regional cingulum disruption in mild cognitive impairment and Alzheimer's disease. Choo IH; Lee DY; Oh JS; Lee JS; Lee DS; Song IC; Youn JC; Kim SG; Kim KW; Jhoo JH; Woo JI Neurobiol Aging; 2010 May; 31(5):772-9. PubMed ID: 18687503 [TBL] [Abstract][Full Text] [Related]
20. Meynert nucleus-related cortical thinning in Parkinson's disease with mild cognitive impairment. Rong S; Li Y; Li B; Nie K; Zhang P; Cai T; Mei M; Wang L; Zhang Y Quant Imaging Med Surg; 2021 Apr; 11(4):1554-1566. PubMed ID: 33816191 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]